EntSun News

Finance News

10500032
Major Financial Milestone Highlights Cycurion, Inc. (N A S D A Q: CYCU) Expanding AI Cybersecurity, Predictive Intelligence and Public-Safety Platform as New Products, Government Contracts and Strategic Acquisitions Drive Its Next Phase of Growth
10500005
ACWORTH, Ga. - -- Cryptocurrency and DEX like Ledger Live and Uniswap is transforming the global financial landscape as blockchain technology creates new opportunities for digital payments, financial innovation, investment, and international commerce...
SALT LAKE CITY - -- Today, American United Federal Credit Union and First Californian officially adopt a single shared name: Haven Credit Union. Already operating as part of the same credit union, both legacy divisions are uniting under one clear...
PHOENIX - -- Mesa West Capital has provided Panattoni Development Company (Panattoni) with a $58.7 million loan to refinance Marbella, a three-building Class A industrial portfolio totaling 445,187 square feet in Glendale, Arizona, a premier industrial...
10499711
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) Has a Certified Sales Force Providing National Coverage with Customers for Approximately 80% of Current U.S. Ketamine Sales
10499474
Commercial Launch Announcement Marks a New Chapter for NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) — FDA-Approved Preservative-Free Ketamine Now Being Sold, 17-Person National Sales Team Activated, Market Relationships Cover Approximately 80% of U.S. Ke
Evolution of an empire: how three generations of the nair lineage transfomed crime from street violence to corporate finance
10498703
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Also Received an $11 Million Dollar Award for Robotic Magnetic Stimulation with Pharma Treatment for Resistant Depression
10498316
A Landmark October 30th FDA Approval, Commercial Manufacturing Readiness, Two-Year Stability Results, and an $11.25 Million DARPA Research Contract Put NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) at an Important Turning Point in Its Growth
New seasonal blog offers parents practical ways to plan family fun before October 31
10497968
$CYCU Boasts a 30 Million Annual Run Rate After Signing Largest Contract Ever, Valued Over $54 Million
10497959
Eagle Springs has restarted with a 5,000-barrel-per-day capacity, a proposed $50 million non-dilutive Nevada oil initiative and a substantial Utah resource opportunity, Sky Quarry $SKYQ is advancing its vision of a more integrated Western U.S. energy plat
Self-paced online training helps learners strengthen their bookkeeping knowledge and gain confidence using QuickBooks Online.
10497490
With relationships spanning 600 telecommunications operators, a potential reach of 2.3 billion end users, and fresh momentum in mobile entertainment, IQSTEL is advancing its strategy to transform a substantial telecommunications platform into a higher-mar
Platform named "Leading AI Procurement & AP Automation Platform 2026" in SME News UK Finance Awards
10497268
NRXP Reports Three Successfully Manufactured Commercial Lots, Two-Year Stability Data, and Commercially Releasable Supply Pending FDA Approval — While an $11.18 Million DARPA Contract Expands the Company's Research Opportunities
10497013
October 15 FDA Update Confirms Minor Labeling Changes Ahead of November 10 Goal Date, While an $11.18 Million DARPA Contract and Innovative Depression Research Expand the Company's Potential
10496630
From "Diagnose and Treat" to "Predict, Alert and Intervene"—POMDOCTOR $POM. New AI-Powered Predictive Healthcare Vision Takes Center Stage in October 12 Announcement.
10496120
New SmallCapVoice interview with $SKYQ puts the spotlight on a restarted Nevada refinery, 5,000-barrel-per-day potential, a non-dilutive $50 million oil-development initiative and Sky Quarry's plans to ramp both Nevada and Utah operations.
10495580
From AI-Powered Chronic Disease Management to "Hardware + AI + Payment," POMDOCTOR Is Building a Broader Digital Healthcare Infrastructure Platform
10495577
Today's landmark defense contract launches the FDA-approved SPARC-TMS trial while NRx simultaneously advances its preservative-free ketamine program, HOPE Therapeutics and an expanding CNS pipeline